Fig 2.
Tigecycline MIC distribution stratified by VAP and non-VAP status (adapted with from reference 3 with permission of the publisher).
Tigecycline MIC distribution stratified by VAP and non-VAP status (adapted with from reference 3 with permission of the publisher).